Analysis of ritonavir in plasma/serum and tissues by high-performance liquid chromatography

This publication has 10 references indexed in Scilit:

• Inhibition of Desipramine Hydroxylation (Cytochrome P450-2D6) in Vitro by Quinidine and by Viral Protease Inhibitors: Relation to Drug Interactions in Vivo
  Journal of Pharmaceutical Sciences, 1998
• The effect of multiple doses of ritonavir on the pharmacokinetics of rifabutin*
  Clinical Pharmacology & Therapeutics, 1998
• Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with Ritonavir
  The Journal of Clinical Pharmacology, 1998
• The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.
  Journal of Clinical Investigation, 1998
• Determination of ritonavir, a new HIV protease inhibitor, in biological samples using reversed-phase high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1997
• Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir
  British Journal of Clinical Pharmacology, 1997
• Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects
  Antimicrobial Agents and Chemotherapy, 1997
• Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients
  AIDS, 1997
• A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease
  New England Journal of Medicine, 1995
• In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
  Nature, 1995